WHO Launches Sixth Virtual Training Initiative to Boost Global Health Standards
Geneva, Monday, 18 August 2025.
The WHO’s virtual cGMP training, launched on 17 August 2025, enhances global health through online education in pharmaceutical manufacturing, aiming to improve regulatory approval and product safety.
A Strategic Move Towards Global Health Improvement
The World Health Organization (WHO) has embarked on a pivotal journey to enhance global health standards by launching its sixth Virtual cGMP Training Marathon on 17 August 2025. This initiative seeks to reinforce current Good Manufacturing Practices (cGMP) across the pharmaceutical and in vitro diagnostics (IVD) sectors. The training aims to bolster both regulatory approval processes and product safety on a global scale by providing comprehensive online education to industry professionals [1].
In-Depth Training for Diverse Stakeholders
WHO’s training marathon spans over the course of two weeks, targeting a range of stakeholders including regulatory authorities, manufacturers, and health professionals worldwide. The primary focus of these sessions is to ensure the adoption of best practices in manufacturing quality systems, addressing critical topics such as data integrity, quality systems, and aseptic processing. The marathon is characterized by interactive sessions conducted by top experts, fostering a robust exchange of ideas and practices [1].
The Role of cGMP in Global Health Security
cGMP forms the backbone of safe and effective pharmaceutical manufacturing, ensuring that products meet the stringent quality standards necessary for protecting public health. In recent years, deficiencies in regulatory oversight have caused critical lapses in product safety, as seen in incidents involving contaminated medications in various countries. WHO’s dedication to enhancing cGMP compliance aims to prevent such occurrences by ensuring that all industry participants are up to date with evolving regulatory requirements and quality assurance practices [1][2].
Long-Term Impact on Healthcare Systems
The long-term impact of these training marathons is profound. By empowering technical professionals with the knowledge necessary to improve manufacturing practices, WHO is not only addressing immediate regulatory needs but also paving the way for long-term advancements in healthcare systems globally. As manufacturers and regulatory bodies become more adept at maintaining both quality and safety, the systemic transformation within the healthcare industry could lead to a significant reduction in health risks associated with substandard pharmaceuticals [1].